L’Oréal acquires a majority stake in British skincare brand Medik8

Published on 09/06/2025 - 16:04 GMT+2

L’Oréal has acquired a mostly liking successful nan UK’s Medik8 arsenic it seeks to grow its position successful nan skincare market, nan French beauty elephantine confirmed connected Monday.

As portion of nan deal, backstage equity patient Inflexion will stay a number shareholder, and nan existent guidance committee will besides enactment successful their roles.

The costs of nan liking is officially undisclosed, though nan Financial Times reported past week that nan imaginable woody was worthy astir €1bn.

L’Oréal’s stock value was astir unchanged connected nan news.

“We are delighted to invited Medik8 to nan L’Oréal family,” said Cyril Chapuy, President of L’Oréal LUXE. “As a premium skincare range, pinch precocious levels of proven efficacy astatine an accessible value point, Medik8 perfectly complements our existing skincare portfolio,” he added.

L’Oréal has been seeking to capitalise connected nan roar successful science-driven skincare, partially driven by societal media influencers.

Brands already nether its “Dermatological Beauty Division” see La Roche-Posay, Cerave, Vichy, Skinceuticals, and Skinbetter Science.

This portion brought successful complete €7bn successful gross successful 2024, representing an almost 10% year-on-year rise, making it L’Oréal’s fastest-growing division.

Seeking to grow its portfolio, L’Oréal bought soap shaper Aesop successful 2023, and Korean beauty marque Dr.G successful December.

Last year, L’Oréal besides acquired a 10% liking successful skincare patient Galderma, arsenic good arsenic acquiring nan beauty licence for Miu Miu.

At nan clip of nan Galderma deal, nan French patient said it was “increasingly investing successful a much holistic approach, spanning nan full beauty routine” — thereby “anticipating and intercepting nan signs of tegument ageing”.

Medik8, founded successful 2009, specialises successful anti-ageing treatments and was bought by UK-based backstage equity patient Inflexion successful 2021.